Efficacy of a Probiotic Formulation on Energy Balance in Overweight Subjects
NCT ID: NCT01066260
Last Updated: 2013-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2009-10-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study was to assess the efficacy of the consumption of a probiotic formulation on energy balance in overweight subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Probiotic on Body Weight
NCT01106924
The Addition of Probiotic Consumption to a Nutritional Intervention and Caloric Restriction on Body Weight and Composition in Overweight Participants
NCT02962583
Impact of Probiotics on Weight Control and Body Composition in Overweight and Obese Individuals
NCT02893943
The Influence of Probiotics on Body Weight and Composition
NCT02465294
Psychophysiological Effects of Probiotic Supplementation
NCT05226520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic
Probiotic formulation
Twice a day for 24 days
Placebo
Placebo
Twice a day for 24 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic formulation
Twice a day for 24 days
Placebo
Twice a day for 24 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy (determined by medical questionnaire)
* Able to commit to the duration of the study
* Providing consent for participation
Exclusion Criteria
* History of gastrointestinal surgery
* History of sleep disorders
* Recent bacterial infection (\< 2 weeks)
* Weight loss \> 5 kg in the last 3 months
* Under antibiotics or treatments (medical or nutritional program) affecting body weight, appetite, energy expenditure lipid-lowering, hypertension or inflammation or glucose control for the last 3 months or taking hormone replacement therapy
* Excessive consumption of products enriched in probiotics (\> 4 servings per week) within the last 4 weeks before the start of the study
* History of drug or alcohol abuse (\> 2 drinks daily)
* Regular smokers (more than 5 cigarettes a day)
* Not eating breakfast regularly or eating breakfast before 6h00.
* Not willing to eat any of the foods to be served in the study for any reason
* Physical activity level \> 150 min of moderate or intense exercise per week
* Concurrent or recent intervention study (within 60 days)
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Beaumont, MD
Role: PRINCIPAL_INVESTIGATOR
Société des Produits Nestlé (SPN)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nestlé Research Center
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-24 MET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.